Krishani Dinali Perera (Krishani D Perera)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Venues

ACS pharmacology & translational science

Journal of medicinal chemistry

Proceedings of the National Academy of Sciences of the United States of America

Science translational medicine

IQVIA

Kansas State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IQVIA

Sri Lanka

Pharmacovigilance analyst :: Pharmacovigilance

Education History

Kansas State University Aug 22 2018

United States

PHD :: Diagnostic Medicine and Pathobiology

Kansas State University

United States

MSC :: Diagnostic Medicine and Pathobiology

University of Peradeniya Faculty of Science

Sri Lanka

BSC

Publications

Chamandi S Dampalla, Athri D Rathnayake, Anushka C Galasiti Kankanamalage, Yunjeong Kim, Krishani Dinali Perera, Harry Nhat Nguyen, Matthew J Miller, Trent K Madden, Hunter R Picard, Hayden A Thurman, Maithri M Kashipathy, Lijun Liu, Kevin P Battaile, Scott Lovell, Kyeong-Ok Chang, William C Groutas
Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease. Journal of medicinal chemistry 65 (11) (2022)
Chamandi S Dampalla, Harry Nhat Nguyen, Athri D Rathnayake, Yunjeong Kim, Krishani Dinali Perera, Trent K Madden, Hayden A Thurman, Alexandra J Machen, Maithri M Kashipathy, Lijun Liu, Kevin P Battaile, Scott Lovell, Kyeong-Ok Chang, William C Groutas
Broad-Spectrum Cyclopropane-Based Inhibitors of Coronavirus 3C-like Proteases: Biochemical, Structural, and Virological Studies. ACS pharmacology & translational science 6 (1) (2022)
Chamandi S Dampalla, Harry Nhat Nguyen, Athri D Rathnayake, Yunjeong Kim, Krishani Dinali Perera, Trent K Madden, Hayden A Thurman, Alexandra J Machen, Maithri M Kashipathy, Lijun Liu, Kevin P Battaile, Scott Lovell, Kyeong-Ok Chang, William C Groutas
Broad-Spectrum Cyclopropane-Based Inhibitors of Coronavirus 3C-like Proteases: Biochemical, Structural, and Virological Studies. ACS pharmacology & translational science 6 (1) (2022)
Yunjeong Kim, Natasha N Gaudreault, David A Meekins, Krishani Dinali Perera, Dashzeveg Bold, Jessie D Trujillo, Igor Morozov, Chester D McDowell, Kyeong-Ok Chang, Juergen A Richt
Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization. bioRxiv : the preprint server for biology (2021)
Chamandi S Dampalla, Jian Zheng, Krishani Dinali Perera, Lok-Yin Roy Wong, David K Meyerholz, Harry Nhat Nguyen, Maithri M Kashipathy, Kevin P Battaile, Scott Lovell, Yunjeong Kim, Stanley Perlman, William C Groutas, Kyeong-Ok Chang
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 118 (29) (2021)
Chamandi S Dampalla, Athri D Rathnayake, Krishani Dinali Perera, Abdul-Rahman M Jesri, Harry Nhat Nguyen, Matthew J Miller, Hayden A Thurman, Jian Zheng, Maithri M Kashipathy, Kevin P Battaile, Scott Lovell, Stanley Perlman, Yunjeong Kim, William C Groutas, Kyeong-Ok Chang
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies. Journal of medicinal chemistry (2021)
Athri D Rathnayake, Jian Zheng, Yunjeong Kim, Krishani Dinali Perera, Samantha Mackin, David K Meyerholz, Maithri M Kashipathy, Kevin P Battaile, Scott Lovell, Stanley Perlman, William C Groutas, Kyeong-Ok Chang
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice. Science translational medicine 12 (557) (2020)

Krishani Dinali Perera.css-eqlu8i{font-size:small;padding-left:4px;} (Krishani D Perera)

Publication Activity (10 Years)

Top Topics

Top Venues

Krishani Dinali Perera (Krishani D Perera)